The Innate Immune Signalling Pathways: Turning RIG-I Sensor Activation against Cancer
Article in Cancers (October 2020)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
Therapeutically active RIG-I agonist induces immunogenic tumor cell killing in breast cancers
Article in Cancer Research (November 2018)
Epigenetic of Retinoic Acid Receptor β2 Gene in Breast Cancer
Book chapter (March 2015)